Lipids in Pulmonary Drug Delivery (Original Publisher)

Lipids in Pulmonary Drug Delivery (1st Edition, 2025) is a groundbreaking resource that examines the evolving role of lipids as carriers in the targeted delivery of respiratory medications. As respiratory diseases like asthma, COPD, pulmonary fibrosis, and infections demand more precise and efficient therapies, lipid-based drug delivery systems are emerging as key innovations in pulmonary pharmacology.

Published by Elsevier, this book serves as an authoritative guide for pharmaceutical scientists, formulation chemists, clinical researchers, and healthcare professionals involved in respiratory drug design and development. With its multidisciplinary approach, it covers the chemical, pharmacokinetic, and clinical aspects of lipid-based formulations, highlighting their potential in enhancing bioavailability, reducing side effects, and improving patient outcomes.

Key Features and Highlights

• Comprehensive review of lipid-based systems in pulmonary drug delivery
• Insights into liposomes, solid lipid nanoparticles, and nanostructured lipid carriers
• Focus on formulation techniques, stability, and aerosol performance
• Covers preclinical studies and translational challenges
• Analysis of current and emerging applications in chronic and infectious lung diseases
• Contributions from global experts in pharmaceutics, nanotechnology, and pulmonary medicine

Topics Covered

This edition includes core chapters on:

• Lipid-based nanocarriers for inhalation therapies
• Drug-lipid interactions and pulmonary absorption dynamics
• Formulation strategies for dry powder inhalers and nebulizers
• Lipid nanoparticles for gene and vaccine delivery via the lungs
• Regulatory and safety considerations in lipidic drug delivery systems
• Clinical case studies in lipid-enhanced pulmonary therapeutics

About the Author

The editor is a recognized leader in pharmaceutical sciences and pulmonary drug delivery, with an extensive publication record and experience in translational nanomedicine. Their work bridges academia and industry, shaping the future of targeted respiratory therapy.

Format and Compatibility

• Available Formats: PDF
• File Size: Approx. 10–14 MB
• Language: English
• Device Compatibility: Compatible with Kindle, iOS, Android, laptops, and all major e-readers

FAQs

Q1: Is this book suitable for academic researchers or industry professionals?
A: Both. It’s designed for academic researchers exploring lipid-based delivery platforms as well as industry scientists developing next-generation inhalation therapies.

Q2: Does the book address lipid formulations for both chronic and infectious pulmonary diseases?
A: Yes. It covers a wide spectrum of applications, including treatment of asthma, COPD, pulmonary infections, and the delivery of vaccines via the respiratory tract.